112 related articles for article (PubMed ID: 16168296)
21. Temporal trends in target vessel revascularization in clinical practice: long-term outcomes following coronary stenting from the Duke Database for Cardiovascular Disease.
Kandzari DE; Tuttle RH; Zidar JP; Jollis JG
J Invasive Cardiol; 2006 Sep; 18(9):398-402. PubMed ID: 16954575
[TBL] [Abstract][Full Text] [Related]
22. Genetic markers of restenosis after coronary angioplasty and after stent implantation.
Petrovic D; Peterlin B
Med Sci Monit; 2005 Apr; 11(4):RA127-35. PubMed ID: 15795709
[TBL] [Abstract][Full Text] [Related]
23. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
[TBL] [Abstract][Full Text] [Related]
24. No association found between the insertion/deletion of a 287-bp alu repeat sequence within intron 16 of the angiotensin-I-converting enzyme (ACE) gene in Mexican patients and binary restenosis after coronary stenting.
Martínez-Ríos MA; Peña-Duque MA; Fragoso JM; Delgadillo-Rodríguez H; Pérez-Hernández N; Miranda-Malpica E; Rodríguez-Pérez JM; González-Quesada C; Vargas-Alarcón G
Clin Chim Acta; 2008 Nov; 397(1-2):65-7. PubMed ID: 18706898
[TBL] [Abstract][Full Text] [Related]
25. Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diabetic nephropathy.
Ng MC; Baum L; So WY; Lam VK; Wang Y; Poon E; Tomlinson B; Cheng S; Lindpaintner K; Chan JC
Clin Genet; 2006 Jul; 70(1):20-8. PubMed ID: 16813599
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein lipase 1595 c/g and hepatic lipase -480 c/t polymorphisms--impact on lipid profile in incident dialysis patients.
Chmielewski M; Stenvinkel P; Luttropp K; Suliman ME; Qureshi AR; Carrero JJ; Barany P; Heimburger O; Nordfors L; Lindholm B
Blood Purif; 2008; 26(6):555-60. PubMed ID: 19052449
[TBL] [Abstract][Full Text] [Related]
27. Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation.
Canibus P; Faloia E; Piva T; Muçai A; Serenelli M; Perna GP; Boscaro M; Piva R
Metabolism; 2008 May; 57(5):593-7. PubMed ID: 18442619
[TBL] [Abstract][Full Text] [Related]
28. Haplotypes in the lipoprotein lipase gene influence high-density lipoprotein cholesterol response to statin therapy and progression of atherosclerosis in coronary artery bypass grafts.
Goodarzi MO; Taylor KD; Scheuner MT; Antoine HJ; Guo X; Shah PK; Rotter JI
Pharmacogenomics J; 2007 Feb; 7(1):66-73. PubMed ID: 16755277
[TBL] [Abstract][Full Text] [Related]
29. Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease.
Aydogan HY; Isbir S; Kurnaz O; Gormus U; Isbir T
In Vivo; 2009; 23(1):155-61. PubMed ID: 19368142
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention.
Beijk MA; Boekholdt SM; Rittersma SZ; Pons D; Zwinderman AH; Doevendans PA; Tio RA; Tijssen JG; Jukema JW; de Winter RJ
Pharmacogenet Genomics; 2010 Sep; 20(9):544-52. PubMed ID: 20671584
[TBL] [Abstract][Full Text] [Related]
31. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
[TBL] [Abstract][Full Text] [Related]
32. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions.
Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V
Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548
[TBL] [Abstract][Full Text] [Related]
33. Higher platelet activity is present in patients with restenosis after percutaneous coronary intervention compared with patients with an occlusion of coronary artery bypass graft.
Osmancik PP; Bednar F; Pavkova L; Tousek P; Stros P; Jirasek K
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):807-12. PubMed ID: 19002048
[TBL] [Abstract][Full Text] [Related]
34. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
Yan BP; Ajani AE; New G; Duffy SJ; Farouque O; Shaw J; Sebastian M; Lew R; Brennan A; Andrianopoulos N; Reid C; Clark DJ;
Int J Cardiol; 2008 Nov; 130(3):374-9. PubMed ID: 18706719
[TBL] [Abstract][Full Text] [Related]
35. Altered autonomic cardiac control predicts restenosis after percutaneous coronary intervention.
Goernig M; Gramsch M; Baier V; Figulla HR; Leder U; Voss A
Pacing Clin Electrophysiol; 2006 Feb; 29(2):188-91. PubMed ID: 16492306
[TBL] [Abstract][Full Text] [Related]
36. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
[TBL] [Abstract][Full Text] [Related]
37. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
38. Association of the lipoprotein lipase gene T+495G polymorphism with central obesity and serum lipids in a twin study.
Li J; Huang A; Hu Y; Chen D
Ann Epidemiol; 2008 Oct; 18(10):760-7. PubMed ID: 18693040
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery.
Thielmann M; Leyh R; Massoudy P; Neuhäuser M; Aleksic I; Kamler M; Herold U; Piotrowski J; Jakob H
Circulation; 2006 Jul; 114(1 Suppl):I441-7. PubMed ID: 16820616
[TBL] [Abstract][Full Text] [Related]
40. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
